Relationship between coronary risk calculation and distribution of the coronary artery lesions and risk factors;Koroner risk katsayisi ile koroner anjiyogrfik olarak damar tutulum ve risk faktörleri arasindaki ilişki

Anadolu Kardiyoloji Dergisi

Volumn 6, Issue 4, 2006, Pages 353-357

  Saǧ, Cemal ^a   Özkan, Mustafa ^a   Uzun, Mehmet ^a   Yokuşoǧlu, Mehmet ^a   Baysan, Oben ^a   Erinç, Kürşad ^a   Işik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary angiography; Coronary artery disease; Coronary risk calculation

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 33846398395     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Onat A, Dursunoǧlu D, Kahraman G, Ökçün B, Dönmez K, Keleş I, ve ark. Türk Erişkinlerinde Ölüm ve Koroner Olaylar: TEKHARF Çalişmasi Kohortunun 5-Yillik Takibi. Türk Kardiyol Dern Arş 1996; 24: 8-15.
2. World Health Organization. The World Health Report, 2002. Geneva: World Health Organization, 2002.
3. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998; 97: 1837-47.
4. Wood D, De Bucker G, Faergeman O, Graham I, Mancia G, Pyoröla K. On behalf of the Joint Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of task force of European and other societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
5. Lee W, Min WK, Chun S, Jang S, Kim JQ, Lee do H, et al. Low-density lipoprotein subclass and its correlating factors in diabetics. Clin Biochem 2003; 36: 657-61.
6. Cantin B, Lamarche B, Despres JP, Dagenais GR. Does correction of the Friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study. Atherosclerosis 2002; 163: 261-7.
7. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003; 21: 315-25.
8. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003; 108: 161-5.
9. Puri A, Gupta OK, Dwivedi RN, Bharadwaj RP, Narain VS, Singh S. Homocysteine and lipid levels in young patients with coronary artery disease. J Assoc Physicians India. 2003; 51: 681-5.
10. Harjai KJ. Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein (a), triglycerides, oxidative stress, and fibrinogen. Ann Intern Med 1999; 131: 376-86.
11. Zhang X, Jiang H, Lai J. Relationship between the risk factors of coronary artery disease and the severity of coronary artery lesions. Zhonghua Yi Xue Za Zhi. 1998; 78: 49-51.
12. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG et al. Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003; 42: 1161-70.
13. Weitzman D, Goldbourt U.The significance of various blood pressure indices for long-term stroke, coronary heart disease, and all-cause mortality in men. The Israeli Ischemic Heart Disease Study. Stroke 2006; 37: 358-63.
14. Black HR.The paradigm has shifted to systolic blood pressure. J Hum Hypertens 2004; 18 Suppl 2: S3-7.
15. Linton MF, Fazio S. National Cholesterol Education Program (NCEP)-the third Adult Treatment Panel (ATP III). A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol 2003; 92(Suppl 1A): 19i-26i.
16. Lazarova Z, Edelsteinova S, Czirfusz A, Drabkova E. Relation between hepatic lipid metabolism and the formation of lipid plaques in the rabbit aorta in an experimental model of atherosclerosis. Cas Lek Cesk 1991; 130: 548-52.
17. Assmann G, Nofer JR. Atheroprotective effects of high-density lipoproteins. Annu Rev Med. 2003; 54: 321-41.
18. Taskinen MR. LDL-cholesterol, HDL-cholesterol or triglycerides, which is the culprit? Diabetes Res Clin Pract 2003; 61 Suppl 1: S19-26.
19. Gotto AM Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J 2002; 144 (Suppl): S33-42.
20. Sprecher DL, Watkins TR, Behar S, Brown WV, Rubins HB, Schaefer EJ. Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease. Am J Cardiol 2003; 91: 575-80.
21. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pépin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-59.
22. Mahley RW, Pépin GM, Bersot TP, Algan Z, Palaoǧlu KE. Low HDL-C in Turks: genetic/lifestyle interactions modulate plasma levels Türk Kardiyol Dern Arş 2005; 33: 381-91.
23. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17: 107-13.
24. Mahley RW, Pépin GM, Bersot TP, Palaoglu KE, Özer K. New findings of the Turkish Heart Study: guiding treatment suggestions for levels of plasma lipids and low HDL. Türk Kardiyol Dern Arş 2002; 30: 93-103.
25. Mahley RW, Mahley LL, Bersot TP, Pépin GM, Palaoglu KE. The Turkish lipid problem: Low levels of high density lipoproteins. Turk J Endocrinol Metab 2002; 6: 1-12.
26. Koenig W, Sund M, Frölich M. C-reactive protein a sensitive marker of inflammation predict future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237-42.
27. Biasucci LM, Liuzzo G, Fantuzzi G. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in hospital coronary events. Circulation 1999; 99: 2079-84.
28. Sukhova G, Schönbeck U, Rabkin E. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in human vulnerable atherosclerotic plaques. Circulation 1999; 99: 2503-8.